Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引：0
|
作者：
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I：
10.1016/j.jtho.2018.08.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-02
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [21] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Takemoto, Shinnosuke
    Nagashima, Seiji
    Soda, Hiroshi
    Fukuda, Minoru
    Nakamura, Yoichi
    Iida, Tetsuya
    Nakatomi, Katsumi
    Kasai, Takashi
    Takatani, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S468 - S469
  • [22] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Kasai, T.
    Fukuda, M.
    Nakamura, Y.
    Nakatomi, K.
    Iida, T.
    Fukuda, M.
    Kinoshita, A.
    Soda, H.
    Oka, M.
    Kohno, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 539 - 540
  • [23] A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer
    Inoue, Akira
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Takuji
    Kimura, Yuichiro
    Kanbe, Mariko
    Isobe, Hiroshi
    Nishimura, Masaharu
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 551 - 555
  • [24] A PHASE II STUDY OF AMRUBICIN AND TOPOTECAN COMBINATION THERAPY IN PATIENTS WITH RELAPSED OR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER: OKAYAMA LUNG CANCER STUDY GROUP TRIAL 0401
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Shinkai, Tetsu
    Katou, Yuka
    Hotta, Katsuyki
    Takigawa, Nagio
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S643 - S644
  • [25] A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Kuyama, Shoichi
    Kiura, Katsuyuki
    Takigawa, Nagio
    Chikamori, Kenichi
    Shibayama, Takuo
    Kishino, Daizo
    Hosokawa, Shinobu
    Tamaoki, Akihiko
    Harita, Shingo
    Tabata, Masahiro
    Ueoka, Hiroshi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    LUNG CANCER, 2011, 74 (01) : 80 - 84
  • [26] Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
    Takashi Yana
    Shunichi Negoro
    Minoru Takada
    Soichiro Yokota
    Yoshiki Takada
    Takahiko Sugiura
    Hidehiko Yamamoto
    Toshiyuki Sawa
    Masaaki Kawahara
    Nobuyuki Katakami
    Yutaka Ariyoshi
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 253 - 258
  • [27] Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
    Yana, Takashi
    Negoro, Shunichi
    Takada, Minoru
    Yokota, Soichiro
    Takada, Yoshiki
    Sugiura, Takahiko
    Yamamoto, Hidehiko
    Sawa, Toshiyuki
    Kawahara, Masaaki
    Katakami, Nobuyuki
    Ariyoshi, Yutaka
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (03) : 253 - 258
  • [28] Amrubicin Monotherapy for Elderly Patients with Previously Treated Lung Cancer
    Nakao, Makoto
    Oguri, Tetsuya
    Suzuki, Takeshi
    Kunii, Eiji
    Tomita, Yuki
    Iwashima, Yasuhito
    Miyazaki, Mikinori
    Maeno, Ken
    Sato, Shigeki
    Ueda, Ryuzo
    INTERNAL MEDICINE, 2010, 49 (17) : 1857 - 1862
  • [29] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
    Hirose, T.
    Shirai, T.
    Kusumoto, S.
    Sugiyama, T.
    Yamaoka, T.
    Okuda, K.
    Ohmori, T.
    Ohnishi, T.
    Adachi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
12345